Peripheral blood progenitor cell (PBPC) counts during steady-state hematopoiesis allow to estimate the yield of mobilized PBPC after filgrastim (R-metHuG-CSF)-supported cytotoxic chemotherapy.
暂无分享,去创建一个
R. Möhle | C. Conradt | S. Fruehauf | R. Haas | S. Murea | W. Hunstein | B. Witt | Werner Hunstein | W. Hunstein